Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatomyositis

S O Kovacs1, S C Kovacs

  • 1Laser and Skin Surgery Center of New York, New York, USA.

Journal of the American Academy of Dermatology
|December 8, 1998
PubMed
Summary
This summary is machine-generated.

Dermatomyositis is a rare inflammatory myopathy causing skin issues and muscle weakness. While immunosuppressive treatments help many, significant illness and complications persist in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitiligo.

Journal of the American Academy of Dermatology·1998
Same author

Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production.

The Journal of biological chemistry·1996
Same author

Mood changes associated with isotretinoin and substance abuse.

Pediatric dermatology·1996
Same author

Superficial fungal infections. Getting rid of lesions that don't want to go away.

Postgraduate medicine·1995
Same author

Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing.

The Journal of clinical investigation·1993
Same author

Lateral medullary syndrome following varicella infection.

American journal of diseases of children (1960)·1993
Same journal

"Highlights from JAAD International: Noninvasive imaging for basal cell carcinoma".

Journal of the American Academy of Dermatology·2026
Same journal

Effect of Primary Prophylaxis for Pneumocystis Pneumonia in Patients on Rituximab for Immune-Mediated Dermatologic Conditions: A Systematic Review and Meta-Analysis.

Journal of the American Academy of Dermatology·2026
Same journal

Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study.

Journal of the American Academy of Dermatology·2026
Same journal

Real-World Effectiveness and Safety of Ritlecitinib in Adolescents with Severe Alopecia Areata: A 36-Week Single-Center Study.

Journal of the American Academy of Dermatology·2026
Same journal

Liquid Biopsy in Cutaneous Oncology: Current Practice and Future Directions.

Journal of the American Academy of Dermatology·2026
Same journal

Ethically protecting immunosuppressed patients in shared dermatology spaces.

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Rheumatology and Immunology
  • Dermatology
  • Neurology

Background:

  • Dermatomyositis is a rare inflammatory myopathy characterized by distinct skin rashes and progressive muscle weakness.
  • It presents in various forms, including adult idiopathic, juvenile, amyopathic, and secondary to connective tissue diseases or malignancy.
  • The pathogenesis is complex, involving immunologic, genetic, and environmental factors.

Purpose of the Study:

  • To provide a comprehensive overview of dermatomyositis, encompassing its classification, pathogenesis, and treatment.
  • To highlight the current understanding of the immunologic underpinnings of the disease.
  • To discuss the efficacy and limitations of existing therapeutic strategies.

Main Methods:

  • Literature review of existing studies on dermatomyositis.

Related Experiment Videos

  • Analysis of immunologic pathways implicated in disease development.
  • Evaluation of treatment outcomes with immunosuppressive agents.

    • Main Results:

    • Dermatomyositis classification includes idiopathic, juvenile, amyopathic, and malignancy-associated forms.
    • Immunologic factors are central to dermatomyositis pathogenesis, with genetic and environmental influences also noted.
    • Immunosuppressive therapy is effective for most patients but does not eliminate all morbidity.

    Conclusions:

    • Dermatomyositis requires a multi-faceted approach considering its varied presentations and complex etiology.
    • Further research into the precise immunologic mechanisms is needed for targeted therapies.
    • Despite treatment advances, managing dermatomyositis morbidity remains a clinical challenge.